# Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites

> **NCT00115947** · PHASE2,PHASE3 · COMPLETED · sponsor: **Hvidovre University Hospital**

## Conditions studied

- Cirrhosis
- Ascites

## Interventions

- **DRUG:** Terlipressin

## Key facts

- **NCT ID:** NCT00115947
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** — (—)
- **Last updated:** 2006-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00115947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00115947, "Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00115947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*